&#xa0;
default&#xa0;
default default              defaultWritten evidence submitted by defaultthe defaultHuman Tissue Authority default(BTO0032)default&#xa0;defaultIntroduction 
default&#xa0;default&#xa0;
default&#xa0;defaultAbout the HTA
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultHTA’s role in ensuring the quality and safety of cells, tissue and organs
default&#xa0;default&#xa0;defaultEnsuring the quality and safety of human tissue and cells used for the treatment of patientsdefault&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultSelection criteria for deceased donors of tissues and/or cells 
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultSelection criteria for living donors of tissues and/or cells 
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultThe HTA inspection process
default&#xa0;
default&#xa0;
defaultEnsuring the quality and safety of organs intended for transplantation default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultReporting and investigating serious adverse events and reactions default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultSupporting effective researchdefault&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultChecking the knowledge and understanding of living donorsdefault&#xa0;
default&#xa0;defaultCollaborative working and support for the sectordefault default&#xa0;
default&#xa0;
default&#xa0;defaultConclusions and recommendations
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultJanuary 2014
default&#xa0;
default&#xa0;default&#xa0;
default&#xa0;
default